Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Albuterol | 1 | 2020 | 211 | 0.630 |
Why?
|
| Pharmacogenetics | 3 | 2021 | 682 | 0.600 |
Why?
|
| HLA-A Antigens | 1 | 2018 | 223 | 0.570 |
Why?
|
| Pharmacists | 1 | 2018 | 260 | 0.500 |
Why?
|
| Medication Errors | 2 | 2018 | 786 | 0.470 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2016 | 198 | 0.470 |
Why?
|
| Epilepsies, Partial | 1 | 2018 | 431 | 0.450 |
Why?
|
| Hospitals, Pediatric | 6 | 2022 | 1846 | 0.440 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 1066 | 0.410 |
Why?
|
| Drug Prescriptions | 2 | 2020 | 1662 | 0.400 |
Why?
|
| Neuropeptides | 1 | 2018 | 951 | 0.400 |
Why?
|
| Methyltransferases | 1 | 2014 | 371 | 0.360 |
Why?
|
| Gene Deletion | 1 | 2018 | 2666 | 0.350 |
Why?
|
| Anticonvulsants | 1 | 2018 | 1921 | 0.290 |
Why?
|
| Electronic Health Records | 3 | 2020 | 4873 | 0.240 |
Why?
|
| Pharmacy Service, Hospital | 2 | 2018 | 134 | 0.230 |
Why?
|
| Asthma | 2 | 2020 | 6270 | 0.200 |
Why?
|
| Fluvoxamine | 1 | 2022 | 77 | 0.190 |
Why?
|
| Analgesics | 2 | 2020 | 1060 | 0.190 |
Why?
|
| Genetic Testing | 2 | 2019 | 3595 | 0.190 |
Why?
|
| Amphetamines | 1 | 2002 | 143 | 0.190 |
Why?
|
| Disaster Planning | 3 | 2022 | 559 | 0.190 |
Why?
|
| Patient Discharge | 3 | 2023 | 3461 | 0.180 |
Why?
|
| Benzalkonium Compounds | 1 | 2020 | 22 | 0.170 |
Why?
|
| Pharmacy | 1 | 2022 | 92 | 0.170 |
Why?
|
| Child | 21 | 2024 | 80564 | 0.170 |
Why?
|
| Substance Abuse Detection | 1 | 2002 | 301 | 0.170 |
Why?
|
| Mass Casualty Incidents | 1 | 2022 | 178 | 0.160 |
Why?
|
| Dystonic Disorders | 1 | 2024 | 353 | 0.160 |
Why?
|
| Current Procedural Terminology | 1 | 2020 | 100 | 0.160 |
Why?
|
| Methylphenidate | 1 | 2002 | 479 | 0.150 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2019 | 89 | 0.150 |
Why?
|
| Off-Label Use | 1 | 2020 | 185 | 0.150 |
Why?
|
| Analgesia | 2 | 2018 | 461 | 0.150 |
Why?
|
| Emergency Service, Hospital | 8 | 2023 | 7875 | 0.140 |
Why?
|
| Dexmedetomidine | 1 | 2022 | 316 | 0.140 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2022 | 624 | 0.140 |
Why?
|
| Epilepsy, Generalized | 1 | 2019 | 183 | 0.130 |
Why?
|
| Bronchodilator Agents | 1 | 2020 | 514 | 0.130 |
Why?
|
| Cross Reactions | 1 | 2018 | 824 | 0.130 |
Why?
|
| Emergency Medical Services | 2 | 2023 | 1938 | 0.120 |
Why?
|
| Needlestick Injuries | 1 | 2015 | 71 | 0.120 |
Why?
|
| Child, Preschool | 12 | 2020 | 42500 | 0.120 |
Why?
|
| Alleles | 2 | 2018 | 6897 | 0.120 |
Why?
|
| Medical History Taking | 2 | 2010 | 777 | 0.120 |
Why?
|
| Finger Injuries | 1 | 2015 | 146 | 0.110 |
Why?
|
| Central Nervous System Stimulants | 1 | 2002 | 1167 | 0.110 |
Why?
|
| Lacerations | 1 | 2015 | 150 | 0.110 |
Why?
|
| Leg Injuries | 1 | 2015 | 179 | 0.110 |
Why?
|
| Molecular Structure | 1 | 2018 | 1885 | 0.110 |
Why?
|
| Medication Reconciliation | 1 | 2015 | 153 | 0.110 |
Why?
|
| Vomiting | 2 | 2015 | 647 | 0.100 |
Why?
|
| Disasters | 2 | 2011 | 520 | 0.100 |
Why?
|
| Cannabinoids | 1 | 2015 | 174 | 0.100 |
Why?
|
| Epinephrine | 1 | 2015 | 783 | 0.100 |
Why?
|
| Drug Interactions | 2 | 2015 | 1417 | 0.100 |
Why?
|
| Benzocaine | 1 | 2011 | 14 | 0.100 |
Why?
|
| Foreign Bodies | 1 | 2015 | 402 | 0.090 |
Why?
|
| Pancreatitis | 1 | 2018 | 1087 | 0.090 |
Why?
|
| Marijuana Abuse | 1 | 2015 | 411 | 0.090 |
Why?
|
| Natural Language Processing | 1 | 2020 | 1203 | 0.090 |
Why?
|
| Models, Theoretical | 2 | 2013 | 3564 | 0.090 |
Why?
|
| Outpatients | 1 | 2018 | 1595 | 0.090 |
Why?
|
| Infant | 5 | 2019 | 36386 | 0.080 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 1604 | 0.080 |
Why?
|
| Blood Coagulation | 1 | 2015 | 1166 | 0.080 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2016 | 1175 | 0.080 |
Why?
|
| Anaphylaxis | 1 | 2015 | 739 | 0.080 |
Why?
|
| False Positive Reactions | 2 | 2015 | 955 | 0.070 |
Why?
|
| Pediatrics | 5 | 2012 | 3606 | 0.070 |
Why?
|
| Humans | 29 | 2024 | 765968 | 0.070 |
Why?
|
| Warfarin | 1 | 2015 | 1494 | 0.060 |
Why?
|
| Information Management | 1 | 2006 | 100 | 0.060 |
Why?
|
| Rescue Work | 1 | 2006 | 58 | 0.060 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 1672 | 0.060 |
Why?
|
| Continuity of Patient Care | 1 | 2012 | 1078 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 2310 | 0.060 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2011 | 1195 | 0.060 |
Why?
|
| Disclosure | 1 | 2010 | 756 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2019 | 6610 | 0.050 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 4270 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 14751 | 0.050 |
Why?
|
| Adolescent | 8 | 2021 | 88835 | 0.050 |
Why?
|
| Triage | 2 | 2006 | 996 | 0.050 |
Why?
|
| Retrospective Studies | 6 | 2022 | 81514 | 0.050 |
Why?
|
| Weaning | 1 | 2022 | 103 | 0.050 |
Why?
|
| Patient-Centered Care | 1 | 2012 | 1458 | 0.050 |
Why?
|
| Patient Participation | 1 | 2010 | 1455 | 0.050 |
Why?
|
| Safety Management | 1 | 2006 | 763 | 0.040 |
Why?
|
| Dystonia | 1 | 2024 | 376 | 0.040 |
Why?
|
| Genomics | 1 | 2016 | 5929 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2012 | 2192 | 0.040 |
Why?
|
| Hospitalization | 1 | 2020 | 10808 | 0.040 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 2172 | 0.040 |
Why?
|
| Conscious Sedation | 1 | 2003 | 531 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2015 | 4862 | 0.040 |
Why?
|
| Female | 10 | 2020 | 396112 | 0.040 |
Why?
|
| Drug Labeling | 1 | 2021 | 250 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2015 | 4736 | 0.040 |
Why?
|
| Ceftriaxone | 1 | 2019 | 176 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2015 | 4697 | 0.040 |
Why?
|
| Transportation of Patients | 2 | 2011 | 178 | 0.040 |
Why?
|
| Drug Hypersensitivity | 1 | 2006 | 902 | 0.040 |
Why?
|
| Relief Work | 2 | 2011 | 132 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 2 | 2022 | 1191 | 0.040 |
Why?
|
| Fasting | 1 | 2003 | 1606 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2019 | 24282 | 0.030 |
Why?
|
| Parents | 2 | 2010 | 3592 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2019 | 1210 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 2016 | 239 | 0.030 |
Why?
|
| United States | 5 | 2020 | 72903 | 0.030 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2015 | 31 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2023 | 1084 | 0.030 |
Why?
|
| Amitriptyline | 1 | 2015 | 109 | 0.030 |
Why?
|
| Equipment Safety | 1 | 2015 | 250 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 16047 | 0.030 |
Why?
|
| Self Administration | 1 | 2015 | 385 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2015 | 552 | 0.030 |
Why?
|
| Boston | 2 | 2019 | 9338 | 0.030 |
Why?
|
| Male | 8 | 2020 | 363698 | 0.030 |
Why?
|
| Disease Management | 1 | 2024 | 2535 | 0.030 |
Why?
|
| International Normalized Ratio | 1 | 2015 | 381 | 0.030 |
Why?
|
| Disabled Children | 1 | 2015 | 250 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2015 | 553 | 0.020 |
Why?
|
| Southwestern United States | 1 | 2011 | 39 | 0.020 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2015 | 497 | 0.020 |
Why?
|
| Southeastern United States | 1 | 2011 | 94 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2018 | 1069 | 0.020 |
Why?
|
| Security Measures | 1 | 2011 | 83 | 0.020 |
Why?
|
| Interviews as Topic | 2 | 2010 | 2739 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2020 | 6322 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 2229 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4260 | 0.020 |
Why?
|
| Hospitals | 1 | 2023 | 3888 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2015 | 553 | 0.020 |
Why?
|
| Academies and Institutes | 1 | 2012 | 326 | 0.020 |
Why?
|
| Critical Illness | 1 | 2022 | 2744 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2022 | 8733 | 0.020 |
Why?
|
| Graft Survival | 1 | 2019 | 3890 | 0.020 |
Why?
|
| Patient Admission | 1 | 2015 | 1365 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 1275 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2020 | 2521 | 0.020 |
Why?
|
| Equipment Design | 1 | 2015 | 3481 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 13400 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2002 | 3719 | 0.020 |
Why?
|
| Acute Disease | 1 | 2018 | 7232 | 0.020 |
Why?
|
| Emergency Medical Tags | 1 | 2006 | 3 | 0.020 |
Why?
|
| Safety | 1 | 2011 | 1157 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 21056 | 0.020 |
Why?
|
| United States Government Agencies | 1 | 2006 | 26 | 0.020 |
Why?
|
| Louisiana | 1 | 2006 | 104 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 10070 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2019 | 4499 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2011 | 1138 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 3620 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 6309 | 0.010 |
Why?
|
| Chloral Hydrate | 1 | 2003 | 28 | 0.010 |
Why?
|
| Laryngismus | 1 | 2003 | 28 | 0.010 |
Why?
|
| Anesthetics, Combined | 1 | 2003 | 43 | 0.010 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2003 | 59 | 0.010 |
Why?
|
| Counseling | 1 | 2011 | 1551 | 0.010 |
Why?
|
| Pentobarbital | 1 | 2003 | 153 | 0.010 |
Why?
|
| Nitrous Oxide | 1 | 2003 | 166 | 0.010 |
Why?
|
| Lorazepam | 1 | 2003 | 155 | 0.010 |
Why?
|
| Diazepam | 1 | 2003 | 215 | 0.010 |
Why?
|
| Point-of-Care Systems | 1 | 2011 | 1217 | 0.010 |
Why?
|
| Midazolam | 1 | 2003 | 267 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 2334 | 0.010 |
Why?
|
| Young Adult | 2 | 2021 | 59889 | 0.010 |
Why?
|
| Medical Order Entry Systems | 1 | 2006 | 521 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15880 | 0.010 |
Why?
|
| Fentanyl | 1 | 2003 | 457 | 0.010 |
Why?
|
| Emergency Treatment | 1 | 2003 | 494 | 0.010 |
Why?
|
| Documentation | 1 | 2006 | 916 | 0.010 |
Why?
|
| Internet | 1 | 2011 | 3106 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2019 | 26346 | 0.010 |
Why?
|
| Medicaid | 1 | 2012 | 2833 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 29922 | 0.010 |
Why?
|
| Health Personnel | 1 | 2011 | 3390 | 0.010 |
Why?
|
| Ketamine | 1 | 2003 | 525 | 0.010 |
Why?
|
| Hypotension | 1 | 2003 | 885 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 18071 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 41649 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2012 | 5508 | 0.010 |
Why?
|
| Middle Aged | 2 | 2021 | 223009 | 0.010 |
Why?
|
| Adult | 2 | 2021 | 223044 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2003 | 2243 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 65188 | 0.010 |
Why?
|
| Patient Selection | 1 | 2003 | 4255 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14652 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 7425 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2003 | 54802 | 0.000 |
Why?
|
| Risk Factors | 1 | 2003 | 74840 | 0.000 |
Why?
|
Concepts
(193)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(53)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_